Skip to content

nTMS for Motor Mapping of Rolandic Lesions

Randomized Controlled Multicenter Trial on the Impact of Presurgical Navigated Transcranial Magnetic Stimulation for Motor Mapping of Rolandic Lesions

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02879682
Acronym
Motorstim
Enrollment
330
Registered
2016-08-26
Start date
2016-08-31
Completion date
2023-04-30
Last updated
2023-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Metastases, Glioma

Keywords

glioma, brain metastases, nTMS

Brief summary

To compare presurgical motor mapping by navigated transcranial magnetic stimulation for surgery (nTMS) of rolandic lesions to surgery with mapping without implementing these data into neuronavigation as control. Primary objective: Permanently new postoperative deficit is lower when the preoperative motor mapping is available to the surgeon

Detailed description

Experimental intervention: presurgical motor mapping by navigated transcranial magnetic stimulation and fusion with intraoperative neuronavigation Control intervention: presurgical motor mapping by navigated transcranial magnetic stimulation without access of the surgeon to this data Follow-up per patient: 6 months Duration of intervention per patient: 45 minutes

Interventions

PROCEDUREnTMS data available for the surgeon

the preoperatively acquired map of the motor cortex by nTMS will be available for the surgeon

PROCEDUREnTMS data not available for the surgeon

the preoperatively acquired map of the motor cortex by nTMS will not be available for the surgeon

Sponsors

Charite University, Berlin, Germany
CollaboratorOTHER
Evangelisches Krankenhaus Bielefeld gGmbH
CollaboratorOTHER
Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

preoperative Mapping

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

Key inclusion criteria: * indication for resection of a supratentorial tumor within or adjacent to the primary motor cortex * preoperative nTMS mapping of the ipsilateral hemisphere * implementation of the mapping data into preoperative planning * continuous MEP monitoring - informed consent Key

Exclusion criteria

* no motor eloquent tumor * infratentorial tumor * no postoperative imaging * prognosis lower than 3 months of survival - age \<18 years

Design outcomes

Primary

MeasureTime frameDescription
Operation-related neurological motor deficit 3 months after surgery as measured by NIHSS scale3 months after surgerydeterioration in NIHSS score

Secondary

MeasureTime frameDescription
change of the approach1 - 7 days before surgeryusing a different direct to approach the lesion (different sulcus, gyrus, sub cortically)
size of craniotomyintraoperativelyin mm ap and lateral
use of intraoperative motor mapping via MEPintraoperativelyyes/no
changed indication for surgery1 - 7 days before surgerytowards surgery, avoids surgery towards biopsy, avoids surgery towards follow-up
duration of surgeryintraoperativelyin min
extent of resectionintraoperativelyin % via volumetry
use of further modalities (fMRI, DTI fiber tracking, SSEP phase reversal)intraoperativelyyes/no
duration of intraoperative motor mapping via MEPintraoperativelyin min

Countries

Germany, Italy, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026